Increased expression of proliferating cell nuclear antigen in liver allograft rejection

Liver Transplantation and Surgery

Volumn 2, Issue 5, 1996, Pages 337-342

  Ray, M B ^a   Schroeder, T ^a   Michaels, S E ^a   Hanto, D W ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE;

ANTIGEN EXPRESSION; ARTICLE; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; LIVER BIOPSY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

EID: 0029829224     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500020502     Document Type: Article

References (24)

1. 1 Miyachi K, Fritzler MJ, Tan EM. Autoantibody to nuclear antigen in proliferating cells. J Immunol 1978 ; 121: 2228–2234.
2. 2 Bravo R, Celis JE. A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells. J Cell Biol 1980 ; 84: 795–802.
3. 3 Wolf HK, Michalopoulos GK. Hepatocyte regeneration in acute fulminant and nonfulminant hepatitis: A study of proliferating cell nuclear antigen expression. Hepatology 1992 ; 15: 707–713.
4. 4 Kawakita N, Seki S, Nagaguchi H, Yanai A, Kuroki T, et al. Analysis of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen/cyclin in embedded tissues from various liver disease fixed in formaldehyde. Am J Pathol 1992 ; 140: 513–520.
5. 5 Kawakita N, Seki S, Yanai A, Sakaguchi H, Kuroki T, Mizognechi Y, et al. Immunocytochemical identification of proliferating cell nuclear antigen (PONA/cyclin). Am J Clin Pathol 1992 ; 97 (suppl 1): S14–S20.
6. 6 Kamel OW, LeBrun DP, Eric DR, Berry GJ, Warnke RA. Growth fraction estimation of malignant lymphomas in formalin‐fixed paraffin embedded tissue using anti PCNA/cyclin 19A2. Am J Pathol 1991 ; 138: 1471–1477.
7. 7 DerVan PA, Magee HM, Buckley C, Carney DN. Proliferating cell nuclear antigen counts in formalin‐fixed paraffin‐embedded tissue correlate with Ki‐67 in fresh tissue. Am J Clin Pathol 1992 ; 97 (suppl 1): S21–S18.
8. 8 Ojanguren I, Ariza A, Llatjos M, Castella E, Mate J, Navaspalacios JJ. Proliferating all nuclear antigen expression in normal, regenerative and neoplastic liver. Hum Pathol 1993 ; 24: 905–908.
9. 9 Koukoulis G, Rayner A, Tan CH, Williams R, Portman B. Immunolocalization of regenerating cells after submassive liver necrosis using PCNA staining. J Pathol 1992 ; 166: 359–368.
10. 10 Kayano K, Yasunaga M, Kubota M, Takenaka K, Yamashita A, Kubo Y, et al. Detection of proliferating hepatocytes by immunohistochemical staining for proliferating nuclear antigen (PCNA) in patients with acute hepatic failure. Liver 1992 ; 12: 132–136.
11. 11 Imal H, Ochs RL, Kiyosawa K, Furura S, Nakamura RM, Tan EM. Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies. Am J Pathol 1992 ; 140: 859–870.
12. 12 Liu YW, Chang KJ, Liu YC. DNA hypomethylation of proliferating cell nuclear antigen gene in human hepatocellular carcinoma is not due to cell proliferation. Cancer Lett 1993 ; 70: 189–196.
13. 13 Demetris AJ, Lasky S, Van Thiel DH. Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with cyclosporine/steroid regimen. Am J Pathol 1985 ; 118: 115–161.
14. 14 Snover DC, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL. Liver allograft rejection. Am J Surg Pathol 1987 ; 11: 1–10.
15. 15 Garcia R, Coltrera MD, Gown AM. Analysis of proliferative grade using acute PCNA/cyclin monoclonal antibodies in fixed embedded tissues. Am J Pathol 1989 ; 134: 733–739.
16. 16 Myer JS, Province M. Proliferative index of breast carcinoma by thymidine labelling: Prognostic power independent of stage, cestrogen and progesterone receptors. Breast Cancer Res Treat 1988 ; 12: 191–204.
17. 17 Dawson AE, Norton JA, Weinberg DS: Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry. Am J Pathol 1990 ; 136: 1115–1124.
18. 18 Tayyoun H, Michaels SE, Ray MB. Amitotic nuclear division of hepatocytes in acute liver necrosis and liver transplantation. Lab Invest 1994 ; 70: 136A (abstr).
19. 19 Desmet VJ, deGroote J, Van Damme B. Acute hepatocellular failure. Hum Pathol 1972 ; 3: 167–182.
20. 20 Koehler A, Michaels SE, Ray MB. Intrahepatic source and location of bile duct (BD) proliferation in fulminant hepatitis. Lab Invest 1994 ; 70: 133A (abstr).
21. 21 Ludwig J, Weisner RH, Batts KP, Perkins JD, Krom RAF. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. Hepatology 1987 ; 7: 476–483.
22. 22 Hubscher SG, Williams A, Davison SM, Young LS, Niedobitek G. Epstein‐Barr virus in inflammatory disease of the liver and liver allografts. An in situ hybridization study. Hepatology 1994 ; 20: 899–907.
23. 23 Randhawa PS, Markin RS, Starzl TE, Demetris AJ. Epstein‐Barr virus associated syndromes in immuno‐suppressed liver transplant recipients; clinical profile and recognition on routine allograft biopsy. Am J Surg Pathol 1990 ; 14: 538–547.
24. 24 Ray MB, Schoreder TJ, Michaels SE, Park S, Hanto DW. Lab Invest 1993 ; 68: 114A (abstr).